Effect of Dientamoeba fragilis eradication on symptoms in children with abdominal pai

Phase 4

• Conditions: dientamoeba fragilis infection; parasitic bowel infection; 10018012; 10037072

• Registration Number: NL-OMON30565
• Lead Sponsor: Onze Lieve Vrouwe Gasthuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

infection with dientamoeba fragilis
age between 4 and 18 years old

Exclusion Criteria

co-infection with a pathogen
IBD (colitis Ulcerosa)
Oncologic patients
immune compromised patients

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Change in symptoms in children with dientamoeba fragilis after treatment with<br /><br>clioquinol and placebo.<br /><br>Parasitological eradication</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>In de gebruikte duur en dosering van behandeling worden zelden bijwerkingen<br /><br>gezien. In zeer hoge dosering kan het middel neurotoxisch zijn. </p><br>